https://www.selleckchem.com/products/lxh254.html
Primary end-points will be the proportion of patients on potentially inappropriate medications and the mean number of such medications per patient. Secondary endpoints will be healthcare resources used, the proportion of patients who die and the mean number of days survived, as well as the cost of medications and cost of healthcare resources used. In line with similar reports and based on our study´sdesign, we hope to obtain statistically significant reductions in the use ofpotentially inappropriate medications and in medication costs ov